GRIFOLS | GRF - Betriebsergebnis





Betriebsergebnis Veränderung Datum
Alcon AG USD 44M 253M 2026-06
Almirall EUR 71.55M 41.32M 2026-06
Amadeus IT EUR 478.3M 12.8M 2026-06
Amarin USD -2.26M 564K 2025-12
argenx SE USD 493M 99M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Bayer EUR 827M 2.7B 2026-06
Cie Automotive EUR 264.84M 21.12M 2025-12
Demant DKK 2.12B 35M 2026-06
Ence Energia y Celulosa EUR -34.9M 2.37M 2026-03
Essilor EUR 2.3B 919M 2026-06
Ferrovial EUR 294M 293M 2026-06
Fresenius EUR 719M 118M 2026-06
Fresenius Medical Care EUR 537.27M 269.27M 2026-06
Genmab DKK 407M 182M 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
GRIFOLS EUR 329M 80M 2026-06
Hikma Pharmaceutical USD 348M 161M 2025-12
Inditex EUR 1.76B 298M 2026-03
Lakefront Biotherapeutics EUR -43.51M 20.19M 2026-06
Merck EUR 1.1B 51M 2026-06
Novartis USD 4.75B 515M 2026-06
Philips EUR 610M 308M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 2.38B 449M 2026-06
Smith & Nephew USD 505M 65M 2026-06
UCB EUR 1.29B 571M 2025-12
Viscofan EUR 49.55M 7.38M 2026-06